“Wondering if MRNA / UK or Canada will need receptor occupancy data for BLA too?”
Good question. If so, CYDY doesn’t have receptor occupancy data for the 350mg trial. The receptor occupancy test for leronlimab wasn’t developed until July of 2019. The receptor occupancy test wasn’t used in the HIV trials until the last 10-20% of the mono trial patients, most of who were on the 525mg or 700mg dose.